Director, Global Market Access

Role: Director, Global Market Access at a biopharma focused on oncology therapeutics, responsible for developing and executing global market access strategies to facilitate patient access to innovative cancer therapies, including a lead asset targeting KIT exon 17 mutations in Systemic Mastocytosis and GIST. Responsibilities: formulate market access strategies across the product lifecycle, identify access opportunities and barriers in US and international markets, integrate payer and HTA considerations into broader development and commercialization plans, lead evidence and HEOR initiatives to support value propositions, develop pricing and reimbursement strategies, and contribute to launch readiness efforts. Requirements: Bachelor's degree (advanced degrees like MBA, MPH, PharmD preferred), 8+ years in pharmaceutical/biotech market access, pricing, reimbursement, or HEOR, with demonstrated experience in oncology or complex therapeutic areas, supporting product development and launches. Skills: deep understanding of US payer dynamics, global pricing and reimbursement landscapes, translating clinical data into payer value, strategic planning, and cross-functional collaboration. High-Value: Oncology, targeted therapies, Systemic Mastocytosis, GIST, product lifecycle management, HEOR integration, HTA strategy, global market access, launch planning. Work setup: based in Waltham, MA or Boulder, CO, with strategic importance on cross-market access and commercial integration.